Insider Selling: Tyme Technologies Inc (NASDAQ:TYME) Major Shareholder Sells 20,000 Shares of Stock

Share on StockTwits

Tyme Technologies Inc (NASDAQ:TYME) major shareholder Michael Demurjian sold 20,000 shares of the firm’s stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $1.14, for a total value of $22,800.00. Following the completion of the transaction, the insider now owns 26,070,521 shares in the company, valued at approximately $29,720,393.94. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Large shareholders that own at least 10% of a company’s stock are required to disclose their transactions with the SEC.

Michael Demurjian also recently made the following trade(s):

  • On Monday, November 25th, Michael Demurjian sold 20,000 shares of Tyme Technologies stock. The shares were sold at an average price of $1.13, for a total transaction of $22,600.00.
  • On Monday, November 18th, Michael Demurjian sold 20,000 shares of Tyme Technologies stock. The shares were sold at an average price of $1.09, for a total transaction of $21,800.00.
  • On Monday, November 11th, Michael Demurjian sold 20,000 shares of Tyme Technologies stock. The stock was sold at an average price of $1.16, for a total value of $23,200.00.
  • On Monday, November 4th, Michael Demurjian sold 20,000 shares of Tyme Technologies stock. The stock was sold at an average price of $1.27, for a total value of $25,400.00.
  • On Monday, October 28th, Michael Demurjian sold 20,000 shares of Tyme Technologies stock. The stock was sold at an average price of $1.36, for a total transaction of $27,200.00.
  • On Monday, October 21st, Michael Demurjian sold 20,000 shares of Tyme Technologies stock. The shares were sold at an average price of $1.40, for a total value of $28,000.00.
  • On Monday, October 14th, Michael Demurjian sold 20,000 shares of Tyme Technologies stock. The stock was sold at an average price of $92.98, for a total value of $1,859,600.00.
  • On Monday, October 7th, Michael Demurjian sold 20,000 shares of Tyme Technologies stock. The stock was sold at an average price of $1.35, for a total transaction of $27,000.00.
  • On Tuesday, October 1st, Michael Demurjian sold 20,000 shares of Tyme Technologies stock. The shares were sold at an average price of $1.42, for a total transaction of $28,400.00.
  • On Monday, September 23rd, Michael Demurjian sold 20,000 shares of Tyme Technologies stock. The stock was sold at an average price of $1.67, for a total transaction of $33,400.00.

Tyme Technologies stock opened at $1.12 on Wednesday. Tyme Technologies Inc has a fifty-two week low of $0.92 and a fifty-two week high of $4.64. The stock has a fifty day moving average of $1.25 and a two-hundred day moving average of $1.24. The company has a market capitalization of $126.50 million, a price-to-earnings ratio of -3.50 and a beta of 0.34.

Tyme Technologies (NASDAQ:TYME) last posted its quarterly earnings data on Monday, November 4th. The company reported ($0.04) EPS for the quarter, topping analysts’ consensus estimates of ($0.06) by $0.02. Research analysts anticipate that Tyme Technologies Inc will post -0.21 earnings per share for the current fiscal year.

A number of equities research analysts recently commented on TYME shares. Zacks Investment Research upgraded shares of Tyme Technologies from a “hold” rating to a “buy” rating and set a $1.50 price objective for the company in a research report on Friday, November 8th. HC Wainwright began coverage on Tyme Technologies in a report on Monday, August 12th. They issued a “buy” rating for the company. Finally, ValuEngine upgraded Tyme Technologies from a “hold” rating to a “buy” rating in a research note on Wednesday, October 2nd.

Several institutional investors have recently added to or reduced their stakes in the business. Squarepoint Ops LLC purchased a new stake in shares of Tyme Technologies during the third quarter worth about $71,000. Morgan Stanley raised its position in shares of Tyme Technologies by 187.8% in the second quarter. Morgan Stanley now owns 139,579 shares of the company’s stock valued at $170,000 after buying an additional 91,081 shares during the last quarter. Perkins Capital Management Inc. lifted its stake in shares of Tyme Technologies by 77.0% during the third quarter. Perkins Capital Management Inc. now owns 142,500 shares of the company’s stock valued at $170,000 after buying an additional 62,000 shares during the period. Paloma Partners Management Co purchased a new position in shares of Tyme Technologies during the second quarter valued at approximately $238,000. Finally, Bank of New York Mellon Corp boosted its position in Tyme Technologies by 5.9% during the second quarter. Bank of New York Mellon Corp now owns 306,199 shares of the company’s stock worth $374,000 after acquiring an additional 17,173 shares during the last quarter. 12.93% of the stock is currently owned by institutional investors.

About Tyme Technologies

Tyme Technologies, Inc, a clinical-stage biotechnology company, develops novel cancer therapeutics. It is developing SM-88, a combination therapy based on dysfunctional metyrosine derivatives in Phase II development for metastatic pancreatic cancer and biomarker-recurrent prostate cancer. The company was founded in 2011 and is headquartered in New York, New York.

See Also: What is the Coverage Ratio?

Insider Buying and Selling by Quarter for Tyme Technologies (NASDAQ:TYME)

Receive News & Ratings for Tyme Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tyme Technologies and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.